Page last updated: 2024-10-31

acecainide and Tachycardia, Ventricular

acecainide has been researched along with Tachycardia, Ventricular in 4 studies

Acecainide: A major metabolite of PROCAINAMIDE. Its anti-arrhythmic action may cause cardiac toxicity in kidney failure.
N-acetylprocainamide : A benzamide obtained via formal condensation of 4-acetamidobenzoic acid and 2-(diethylamino)ethylamine.

Tachycardia, Ventricular: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).

Research Excerpts

ExcerptRelevanceReference
"Procainamide is a useful agent for management of ventricular arrhythmia, however its disposition and appropriate dosing during extracorporeal membrane oxygenation (ECMO) is unknown."4.31Procainamide pharmacokinetics during extracorporeal membrane oxygenation. ( Rosenbaum, AN; Vollmer, NJ; Wieruszewski, PM; Wittwer, ED, 2023)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Vollmer, NJ1
Wittwer, ED1
Rosenbaum, AN1
Wieruszewski, PM1
Mohamed, AN1
Abdelhady, AM1
Spencer, D1
Sowinski, KM1
Tisdale, JE1
Overholser, BR1
Allen, NM1
Page, RL1
Brautigam, RT1
Schuster, M1
Porter, RS1
Nydegger, C1
Kutalek, SP1

Trials

1 trial available for acecainide and Tachycardia, Ventricular

ArticleYear
Comparison of intravenous dosing regimens for maintaining steady-state procainamide levels during programmed ventricular stimulation.
    The American journal of cardiology, 1992, Oct-15, Volume: 70, Issue:11

    Topics: Acecainide; Cardiac Pacing, Artificial; Humans; Immunoenzyme Techniques; Infusions, Intravenous; Inj

1992

Other Studies

3 other studies available for acecainide and Tachycardia, Ventricular

ArticleYear
Procainamide pharmacokinetics during extracorporeal membrane oxygenation.
    Perfusion, 2023, Volume: 38, Issue:2

    Topics: Acecainide; Adult; Arrhythmias, Cardiac; Extracorporeal Membrane Oxygenation; Humans; Procainamide;

2023
Pharmacokinetic modeling and simulation of procainamide and N-acetylprocainamide in a patient receiving continuous renal replacement therapy: a novel approach to guide renal dose adjustments.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2013, Volume: 61, Issue:6

    Topics: Acecainide; Adult; Anti-Arrhythmia Agents; Humans; Male; Models, Biological; Procainamide; Renal Ins

2013
Procainamide administration during pregnancy.
    Clinical pharmacy, 1993, Volume: 12, Issue:1

    Topics: Acecainide; Administration, Oral; Adult; Cardiac Pacing, Artificial; Female; Humans; Pregnancy; Preg

1993